Brams Matthew 4
4 · Cingulate Inc. · Filed Jun 13, 2024
Insider Transaction Report
Form 4
Cingulate Inc.CING
Brams Matthew
EVP and Chief Medical Officer
Transactions
- Award
Stock Option (right to Buy)
2024-06-11+63,324→ 63,324 totalExercise: $1.18Exp: 2034-03-04→ Common Stock (63,324 underlying)
Footnotes (2)
- [F1]The stock option grant was approved by Cingulate Inc.'s board of directors on March 4, 2024, subject to stockholder approval of Amendment No.1 to the Cingulate Inc. 2021 Omnibus Equity Incentive Plan (the "Amendment"). Cingulate's stockholders approved the Amendment on June 11, 2024.
- [F2]The option vests as follows: 50% on the six-month anniversary of the date of grant and the remaining shares in substantially equal monthly installments over the 30-month period following the initial vesting date.